Top 10 pharma leader streamlines CQV

A top-10 global pharma company's hybrid validation approach was labor-intensive with GDP risk, limited visibility and collaboration difficulty across international sites; on Veeva previously, it lacked organization/accessibility and couldn't run Commissioning & Qualification (C&Q) digitally. It implemented Kneat's digital validation platform to standardize C&Q, enabling fully digital testing, document management, and execution aligned to existing SOPs and templates. Results: $900,000 in cost savings on a single project, 20-25% reduction in C&Q execution costs on CAPEX projects, and a 30-40% decrease in validation cycle time. A Global Director, Commissioning & Qualification, said: 'Before, we had Veeva....We had a lot of documentation, but it did not have the level of organization and accessibility that we have with Kneat.'

The customer is anonymised in Kneat’s own case study — not withheld by us.

Kneat is a paperless computer-system and process-validation platform — one of the two dominant players in digitizing the validation evidence GxP systems require before go-live.

This sits in the Ship stage of the AI use-case lifecycle: Named examples from the vendors pharma teams use to get an AI system live inside a real, regulated production workflow — validation, CRM, safety and clinical systems of record.